Materials-driven approaches to understand extrinsic drug resistance in cancer

Justin R. Pritchard, Michael J. Lee and Shelly R. Peyton

Soft Matter, 2022, 18, 3465
DOI: 10.1039/D2SM00071G

Towards a standardized multi-tissue decellularization protocol for the derivation of extracellular matrix materials

Andreea Biehl, Ana M. Gracioso Martins, Zachary G. Davis, Daphne Sze, Leonard Collins, Camilo Mora-Navarro, Matthew B. Fisher and Donald O. Freytes

Biomater. Sci., 2023, 11, 641
DOI: 10.1039/D2BM01012G

Synthetic living materials in cancer biology

Shelly R. Peyton, Lesley W. Chow, Stacey D. Finley, Ashlee N. Ford Versypt, Reginald Hill, Melissa L. Kemp, Ellen M. Langer, Alison P. McGuigan, Aaron S. Meyer, Stephanie K. Seidlits, Krishnendu Roy and Shannon M. Mumenthaler

Nat Rev Bioeng, 2023, 1, 972
DOI: 10.1038/s44222-023-00105-w

Development of an automated high‐content immunofluorescence assay of pSmads quantification: Proof‐of‐concept with drugs inhibiting the BMP/TGF‐β pathways

Valia Khodr, Laura Clauzier, Paul Machillot, Adrià Sales, Elisa Migliorini and Catherine Picart

Biotechnology Journal, 2024, 19
DOI: 10.1002/biot.202400007

Biophysical informatics approach for quantifying phenotypic heterogeneity in cancer cell migration in confined microenvironments

Xingjian Zhang, Michael Mak and Jinbo Xu

Bioinformatics, 2021, 37, 2042
DOI: 10.1093/bioinformatics/btab053

Anomalously diffusing and persistently migrating cells in 2D and 3D culture environments

Igor D. Luzhansky, Alyssa D. Schwartz, Joshua D. Cohen, John P. MacMunn, Lauren E. Barney, Lauren E. Jansen and Shelly R. Peyton

APL Bioengineering, 2018, 2
DOI: 10.1063/1.5019196

Getting the big picture of cell-matrix interactions: High-throughput biomaterial platforms and systems-level measurements

Ruoxing Lei and Sanjay Kumar

Current Opinion in Solid State and Materials Science, 2020, 24, 100871
DOI: 10.1016/j.cossms.2020.100871

Development and investigation of dual potent anticancer drug-loaded nanoparticles for the treatment of lung cancer therapy

Ning Zhou, Weihua Wang, Hanyue Li, Daowen Jiang and Xiao Zhong

Process Biochemistry, 2021, 106, 42
DOI: 10.1016/j.procbio.2021.03.018

OrgDyn: feature- and model-based characterization of spatial and temporal organoid dynamics

Zaki Hasnain, Andrew K Fraser, Dan Georgess, Alex Choi, Paul Macklin, Joel S Bader, Shelly R Peyton, Andrew J Ewald, Paul K Newton and Alfonso Valencia

Bioinformatics, 2020, 36, 3292
DOI: 10.1093/bioinformatics/btaa096

A lineage tree-based hidden Markov model quantifies cellular heterogeneity and plasticity

Farnaz Mohammadi, Shakthi Visagan, Sean M. Gross, Luka Karginov, J. C. Lagarde, Laura M. Heiser and Aaron S. Meyer

Commun Biol, 2022, 5
DOI: 10.1038/s42003-022-04208-9

Engineered ECM models: Opportunities to advance understanding of tumor heterogeneity

Adrian A. Shimpi and Claudia Fischbach

Current Opinion in Cell Biology, 2021, 72, 1
DOI: 10.1016/j.ceb.2021.04.001

Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells

Claudia Tanja Mierke

Cells, 2024, 13, 96
DOI: 10.3390/cells13010096

Three‐dimensional culture models to study drug resistance in breast cancer

Madeline F. Fisher and Shreyas S. Rao

Biotech & Bioengineering, 2020, 117, 2262
DOI: 10.1002/bit.27356

Applicability of drug response metrics for cancer studies using biomaterials

Elizabeth A. Brooks, Sualyneth Galarza, Maria F. Gencoglu, R. Chase Cornelison, Jennifer M. Munson and Shelly R. Peyton

Phil. Trans. R. Soc. B, 2019, 374, 20180226
DOI: 10.1098/rstb.2018.0226

Systems biology approaches to measure and model phenotypic heterogeneity in cancer

Aaron S. Meyer and Laura M. Heiser

Current Opinion in Systems Biology, 2019, 17, 35
DOI: 10.1016/j.coisb.2019.09.002

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

Ancuta Jurj, Calin Ionescu, Ioana Berindan-Neagoe and Cornelia Braicu

J Exp Clin Cancer Res, 2022, 41
DOI: 10.1186/s13046-022-02484-1

Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer

Sarah B. Crist and Cyrus M. Ghajar

Cell Systems, 2018, 6, 268
DOI: 10.1016/j.cels.2018.03.005

The biomimetic extracellular matrix: a therapeutic tool for breast cancer research

Marta Tamayo-Angorrilla, Julia López de Andrés, Gema Jiménez and Juan Antonio Marchal

Translational Research, 2022, 247, 117
DOI: 10.1016/j.trsl.2021.11.008

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

Antonino Glaviano, Hannah Si-Hui Lau, Lukas M. Carter, E. Hui Clarissa Lee, Hiu Yan Lam, Elena Okina, Donavan Jia Jie Tan, Wency Tan, Hui Li Ang, Daniela Carbone, Michelle Yi-Hui Yee, Muthu K. Shanmugam, Xiao Zi Huang, Gautam Sethi, Tuan Zea Tan, Lina H. K. Lim, Ruby Yun-Ju Huang, Hendrik Ungefroren, Elisa Giovannetti, Dean G. Tang, Tullia C. Bruno, Peng Luo, Mads Hald Andersen, Bin-Zhi Qian, Jun Ishihara, Derek C. Radisky, Salem Elias, Saurabh Yadav, Minah Kim, Caroline Robert, Patrizia Diana, Kurt A. Schalper, Tao Shi, Taha Merghoub, Simone Krebs, Anjali P. Kusumbe, Matthew S. Davids, Jennifer R. Brown and Alan Prem Kumar

J Hematol Oncol, 2025, 18
DOI: 10.1186/s13045-024-01634-6

Engineered Biomaterials and Model Systems to Study YAP/TAZ in Cancer

Emma Villares and Sharon Gerecht

ACS Biomater. Sci. Eng., 2024, 10, 5550
DOI: 10.1021/acsbiomaterials.4c01170

Biological role of matrix stiffness in tumor growth and treatment

Boer Deng, Ziyi Zhao, Weimin Kong, Chao Han, Xiaochang Shen and Chunxiao Zhou

J Transl Med, 2022, 20
DOI: 10.1186/s12967-022-03768-y

Synergistically fabricated polymeric nanoparticles featuring dual drug delivery system to enhance the nursing care of cervical cancer

Xiujuan Li and Yan Gao

Process Biochemistry, 2020, 98, 254
DOI: 10.1016/j.procbio.2020.09.010

Matrix Stiffness-Regulated Growth of Breast Tumor Spheroids and Their Response to Chemotherapy

Yunfeng Li, Nancy Khuu, Elisabeth Prince, Huachen Tao, Ningtong Zhang, Zhengkun Chen, Albert Gevorkian, Alison P. McGuigan and Eugenia Kumacheva

Biomacromolecules, 2021, 22, 419
DOI: 10.1021/acs.biomac.0c01287

The role of ADAM8 in the mechanophenotype of MDA-MB-231 breast cancer cells in 3D extracellular matrices

Alexander Hayn, Tony Fischer and Claudia Tanja Mierke

Front. Cell Dev. Biol., 2023, 11
DOI: 10.3389/fcell.2023.1148162

Biophysical determinants of cancer organotropism

Udochi F. Azubuike and Kandice Tanner

Trends in Cancer, 2023, 9, 188
DOI: 10.1016/j.trecan.2022.11.002

A Review on Multicellular Spheroids and Organoids for Breast Cancer Diagnosis and Therapy

Sachin Jadhav, Subha Narayan Rath and Uday Kiran Roopavath

Biomedical Materials & Devices, 2025, 3, 771
DOI: 10.1007/s44174-024-00225-w

Enhanced combinatorial analysis of tumor cell-ECM interactions using design-of-experiment optimized microarrays

Hannah R C Kimmel, Allison L Paxhia, Zahra Adamji and Gregory H Underhill

Biofabrication, 2025, 17, 045005
DOI: 10.1088/1758-5090/adf3e6

Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels

Irina Kopyeva, Ross C. Bretherton, Jessica L. Ayers, Ming Yu, William M. Grady and Cole A. DeForest

ACS Biomater. Sci. Eng., 2025, 11, 2810
DOI: 10.1021/acsbiomaterials.4c01632

Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors

Seiichiro Ishihara and Hisashi Haga

Cancers, 2022, 14, 1049
DOI: 10.3390/cancers14041049

GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids

Nathalie Bock, Farzaneh Forouz, Luke Hipwood, Julien Clegg, Penny Jeffery, Madeline Gough, Tirsa van Wyngaard, Christopher Pyke, Mark N. Adams, Laura J. Bray, Laura Croft, Erik W. Thompson, Thomas Kryza and Christoph Meinert

Pharmaceutics, 2023, 15, 261
DOI: 10.3390/pharmaceutics15010261

Measuring and modelling tumour heterogeneity across scales

Garrett F. Beeghly, Adrian A. Shimpi, Robert N. Riter and Claudia Fischbach

Nat Rev Bioeng, 2023, 1, 712
DOI: 10.1038/s44222-023-00087-9

Extracellular matrix stiffness activates mechanosensitive signals but limits breast cancer cell spheroid proliferation and invasion

Irina Jahin, Thomas Phillips, Stefania Marcotti, Mark-Alexander Gorey, Susan Cox and Maddy Parsons

Front. Cell Dev. Biol., 2023, 11
DOI: 10.3389/fcell.2023.1292775

Tunable hydrogels for controlling phenotypic cancer cell states to model breast cancer dormancy and reactivation

Shantanu Pradhan and John H. Slater

Biomaterials, 2019, 215, 119177
DOI: 10.1016/j.biomaterials.2019.04.022

Emerging Concepts and Tools in Cell Mechanomemory

Tanmay P. Lele, Amy Brock and Shelly R. Peyton

Ann Biomed Eng, 2020, 48, 2103
DOI: 10.1007/s10439-019-02412-z

Human breast tissue engineering in health and disease

Maj-Britt Buchholz, Demi I Scheerman, Riccardo Levato, Ellen J Wehrens and Anne C Rios

EMBO Mol Med, 2024, 16, 2299
DOI: 10.1038/s44321-024-00112-3

Phosphoproteomic Changes Induced by Cell-Derived Matrix and Their Effect on Tumor Cell Migration and Cytoskeleton Remodeling

Adrian A. Shimpi, Erik D. Williams, Lu Ling, Tigist Tamir, Forest M. White and Claudia Fischbach

ACS Biomater. Sci. Eng., 2023, 9, 6835
DOI: 10.1021/acsbiomaterials.3c01034

Mechanisms of breast cancer metastasis: the role of extracellular matrix

Rui Chen, Ranqi Zhang, Famin Ke, Xiurong Guo, Fancai Zeng and Qiuyu Liu

Mol Cell Biochem, 2025, 480, 2771
DOI: 10.1007/s11010-024-05175-x

Systems approaches to uncovering the contribution of environment-mediated drug resistance

Marc Creixell, Hyuna Kim, Farnaz Mohammadi, Shelly R. Peyton and Aaron S. Meyer

Current Opinion in Solid State and Materials Science, 2022, 26, 101005
DOI: 10.1016/j.cossms.2022.101005

Challenges and Opportunities Modeling the Dynamic Tumor Matrisome

Shelly R. Peyton, Manu O. Platt and Edna Cukierman

BME Front, 2023, 4
DOI: 10.34133/bmef.0006

The role of matrix stiffness in breast cancer progression: a review

Ruoxi Xu, Peng Yin, Jifu Wei and Qiang Ding

Front. Oncol., 2023, 13
DOI: 10.3389/fonc.2023.1284926

RETRACTED: Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells

Chenggang Lei, Di Liu, Qian Zhou, Shengwei Ma and Haiyun Qian

Heliyon, 2024, 10, e36580
DOI: 10.1016/j.heliyon.2024.e36580

Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug Efficacy

Yufeng Shou, Xin Yong Teo, Xianlei Li, Le Zhicheng, Ling Liu, Xinhong Sun, Win Jonhson, Jun Ding, Chwee Teck Lim and Andy Tay

ACS Nano, 2023, 17, 2851
DOI: 10.1021/acsnano.2c11278